NICE, France, Sept. 16, 2015 /CNW/ -- The Angiogenesis Foundation (www.angio.org) released a white paper today addressing the needs, challenges, and proposed solutions in Canada for preventing vision loss from diabetes. Diabetes, affecting more than 2.4 million Canadians, damages many organs including the eye. Diabetic macular edema (DME), which causes swelling in the back of the eye, can cause moderate to severe, and even permanent, vision loss, and is a leading cause of vision loss.
The white paper, "Advocating for Improved Treatment and Outcomes for Diabetic Macular Edema in Canada," is the result of a multi-stakeholder expert summit convened in Toronto this past January by the Angiogenesis Foundation, including leading expert clinicians in the field, as well as researchers, patients, and patient advocates. The group identified a growing body of evidence suggesting that, despite Canada's well-respected health system, many people with diabetes in Canada are not adequately screened or receiving the optimal care that they need to maintain and prevent progressive vision loss. A new form of treatment called "anti-VEGF therapy" can prevent progressive vision loss and in some cases, even reverse lost vision.
The white paper addresses the current state of the field, identifies future goals and the barriers to those goals, and makes recommendations for action to be taken by advocacy leaders, ophthalmologists, optometrists, and the diabetes community at large for improving vision outcomes in Canada. The report will be distributed at the 15th Euretina Congress in Nice, France and can be downloaded here: DME White Paper Canada.
The Angiogenesis Foundation is a nonprofit organization based in Cambridge, Massachusetts, USA that works with multiple healthcare stakeholders and leads national and global programs to improve health through angiogenesis, the process used by the body to control blood vessel growth.
SOURCE The Angiogenesis Foundation
For further information: Maria Aufiero, 617-401-2779, firstname.lastname@example.org, http://www.angio.org